Skip to Content

New Drug Approvals Archive - March 2003

March 2003

Fuzeon (enfuvirtide)

Date of Approval: March 13, 2003
Company: Roche
Treatment for: HIV Infection

Fuzeon (enfuvirtide) is a fusion inhibitor used in combination with other medicines to treat HIV infection.

Femring (estradiol acetate) Vaginal Ring

Date of Approval: March 20, 2003
Company: Galen Ltd
Treatment for: Postmenopausal Symptoms

Femring (estradiol acetate) is a vaginal estrogen product in the form of a flexible, self-inserted ring. Femring is indicated to treat both the hot flushes and vaginal symptoms associated with menopause.

Somavert (pegvisomant) for Injection

Date of Approval: March 25, 2003
Company: Pharmacia and Upjohn
Treatment for: Acromegaly

Somavert (pegvisomant) is a growth hormone receptor antagonist indicated for the treatment of acromegaly.

Emend (aprepitant) Capsules

Date of Approval: March 27, 2003
Company: Merck
Treatment for: Nausea/Vomiting -- Chemotherapy Induced

Emend (aprepitant) is a substance P/neurokinin 1 (NK1) receptor antagonist used in combination with other antiemetic agents to prevent and control acute and delayed nausea and vomiting associated with chemotherapy.

New Drug Approvals Archive

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.